Skip to main content

Questions and answers

Is obesity hereditary?

Short answer

Yes, obesity is largely hereditary. Twin studies show that genetic factors explain a large proportion of why some people store fat more easily than others. But heritability is not destiny — genes influence the risk, whilst lifestyle habits and the environment determine how genetic traits are expressed.

What does it mean that obesity is hereditary?

When researchers say that a disease is hereditary, they mean that part of the variation between individuals can be explained by genetic differences. For obesity, this genetic component is strong: children of parents with obesity run a significantly higher risk of developing obesity themselves, even after adjusting for dietary habits and living environment.

Importantly: high heritability does not mean that the disease cannot be influenced. It means that a person with the predisposition gains weight more easily with the same food intake and the same amount of physical activity as someone without the predisposition. The starting conditions are simply different.

Which genes are involved?

There is no single "obesity gene". In most cases, obesity is polygenic, which means that hundreds of genes each contribute a small effect. Together, they affect:

  • Appetite and satiety — Variants of the FTO gene (Fat Mass and Obesity-associated gene) affect how much someone eats before feeling full.
  • Energy metabolism — How efficiently the body burns calories at rest.
  • Fat storage — Where on the body fat is stored and how easily it is mobilised.
  • The reward system — How much satisfaction the brain experiences from food.

In rare cases, a single gene can cause severe obesity in children — known as monogenic obesity. These cases are usually identified early in life and investigated at specialist clinics.

Why is it so difficult to lose weight then?

The body has strong biological systems that defend a "set point" weight. When someone with a genetic predisposition to obesity reduces their food intake, the body lowers its metabolic rate and increases feelings of hunger. This is not a "lack of willpower" — it is an inbuilt protective system that acts more strongly in some people than others.

This is one of the reasons why obesity is classified as a chronic disease rather than a lifestyle problem, and why treatment often needs to be long-term and comprehensive.

If I have obesity myself, will my child develop it?

The risk is increased, but not predetermined. Children who have one or two parents with obesity have a statistically higher risk, but many children with a genetic risk never develop obesity — and many without known heritability do. Protective factors include:

  • Regular meal routines from an early age.
  • Daily physical activity — at least 60 minutes per day is recommended.
  • Limited access to energy-dense drinks and ultra-processed foods.
  • Sufficient sleep.
  • Lifestyle habits for the entire family rather than interventions directed solely at the child.

Child health services (BVC, child health centre) monitor the child's BMI curve from an early age, and Swedish clinical practice is to ask about family history as early as registration. If there is a family history of obesity, it is particularly important to monitor the child's BMI trajectory over time.

What does Swedish research show?

The Swedish twin study CATSS (Child and Adolescent Twin Study in Sweden), run by Karolinska Institutet, is one of the world's largest studies of nature and nurture in children. The study compares identical and non-identical twins to estimate how much of the variation in health and behaviour can be explained by genes versus the rearing environment.

Results from international research indicate that the heritability of BMI lies in the range of 40–70 per cent depending on age group and methodology. This is comparable to or higher than the heritability of many other common chronic diseases.

Can heritability be addressed with medication?

The new obesity medications in the GLP-1 analogue class (such as Saxenda and Wegovy) act partly on the same biological systems that genes influence — they affect satiety signals and appetite regulation. In children, these medications are used only within specialist care and in accordance with the national care programme. The medications are not a standalone solution, but an adjunct to lifestyle treatment in selected cases.

Related questions

See all questions and answers →

Sources

  1. 1177 Vårdguiden — Obesity, overweight and obesity in children
  2. Viss.nu — Care programme for overweight in children and adolescents, Region Stockholm
  3. Rikshandboken i barnhälsovård — Increasing BMI, overweight and obesity
  4. Karolinska Institutet — CATSS (Child and Adolescent Twin Study in Sweden)
  5. Läkartidningen — New possibilities in the treatment of children and adolescents with obesity
  6. Västra Götalandsregionen — Childhood obesity, decision support

Last updated: April 2026